Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP492086.RAleDZHn51GWyIKXcf24Cz6xcLDzOL6sshHuqA_HbAF9Q130_assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492086.RAleDZHn51GWyIKXcf24Cz6xcLDzOL6sshHuqA_HbAF9Q130_provenance.
• NP414019.RACsNHpr9VYNQwwAKLZX6ynpYp9jA3OEj7xCc2ETwIgqU130_assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414019.RACsNHpr9VYNQwwAKLZX6ynpYp9jA3OEj7xCc2ETwIgqU130_provenance.
• NP523665.RAB8xtojVxs6rT7-7uwI2GhN_3j4gm7YQ8LSMXldiz1Y0130_assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523665.RAB8xtojVxs6rT7-7uwI2GhN_3j4gm7YQ8LSMXldiz1Y0130_provenance.
• NP686890.RAbArfUwwtAjSl1RMm59L5ebA0GjGeZT0KoWrBg1MwXEg130_assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686890.RAbArfUwwtAjSl1RMm59L5ebA0GjGeZT0KoWrBg1MwXEg130_provenance.
• NP542277.RAXSEEoD497Xg5UOmS0WBVaaJm45754oidS3iRLdKgIwU130_assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542277.RAXSEEoD497Xg5UOmS0WBVaaJm45754oidS3iRLdKgIwU130_provenance.
• NP638704.RA44uNA0c6_124b1IRUzK-VSbPwbImmg00xLw_GNGu9Fs130_assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638704.RA44uNA0c6_124b1IRUzK-VSbPwbImmg00xLw_GNGu9Fs130_provenance.
• NP381254.RAeGOO2GKfT10FQKcVDb7eGebRIo6bLDEiH3E4N5vp-xI130_assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381254.RAeGOO2GKfT10FQKcVDb7eGebRIo6bLDEiH3E4N5vp-xI130_provenance.
• NP381590.RAcGKy6sdHsLPnk_6hGOkQkAhTZaOovCTfdDfyEQkkFdM130_assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381590.RAcGKy6sdHsLPnk_6hGOkQkAhTZaOovCTfdDfyEQkkFdM130_provenance.
• assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP877282.RAMLmA8k9LramQUv_qrNxpuO7IVBAlA9Okej80jIih50I130_assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877282.RAMLmA8k9LramQUv_qrNxpuO7IVBAlA9Okej80jIih50I130_provenance.
• NP877284.RAKX63VttO9pqCs_tDuJb6w2RCHYSLDbdx8cpzx8nGbec130_assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877284.RAKX63VttO9pqCs_tDuJb6w2RCHYSLDbdx8cpzx8nGbec130_provenance.
• NP877279.RAgL6biyYsxjAzlSSbdOaIK6n_sHRji6UClBP884befoY130_assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877279.RAgL6biyYsxjAzlSSbdOaIK6n_sHRji6UClBP884befoY130_provenance.
• NP877283.RAjeKb80xXmfZcjSQgGorxsIYll7mNujENMbUTgR-sY90130_assertion description "[On this basis, a retrospective study of mRNA expression of BRCA1 (breast cancer susceptibility 1 gene), XPG (Xeroderma pigmentosum group G gene) and ERCC1 (excision-repair cross complementing group 1 gene) in tumour samples from sarcoma patients treated with trabectedin was conducted, to correlate DNA repair profiles with patient outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877283.RAjeKb80xXmfZcjSQgGorxsIYll7mNujENMbUTgR-sY90130_provenance.